| Literature DB >> 21351 |
R J O'Reilly, B Dupont, S Pahwa, E Grimes, E M Smithwick, R Pahwa, S Schwartz, J A Hansen, F P Siegal, M Sorell, A Svejgaard, C Jersild, M Thomsen, P Platz, P L'Esperance, R A Good.
Abstract
A patient with severe combined immunodeficiency received seven transplants of bone marrow from an HLA-B-compatible and HLA-D-compatible unrelated donor in an attempt to provide immunologic reconstitution. The first four transplants achieved restricted engraftment with evidence of rudimentary immunologic function. A fifth transplant, given after low-dose cyclophosphamide, produced reconstituion of cell-mediated immunity. Marrow aplasia developed after recontamination with a nonpathogenic microflora. Transplantation of marrow previously stored in liquid nitrogen was ineffective. A subsequent transplant, administered after high-dose cyclophosphamide, achieved durable engraftment, with complete hematopoietic and immunologic reconstitution. Seventeen months after transplantation, full functional engraftment persists. Graft-versus-host disease has been chronic and moderately severe, but limited to the skin and oral mucosa. Transplantation of marrow from unrelated histocompatible donors may provide a useful treatment for patients with severe combined immunodeficiency or aplastic anemia who lack a matched sibling or related donor.Entities:
Mesh:
Substances:
Year: 1977 PMID: 21351 DOI: 10.1056/NEJM197712152972403
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245